Our latest COVID-19 information - full Autumn programme of webinars now in place
  • Home
  • The Pharma Mini MBA

The Pharma Mini MBA Training Course

A three-day accelerated management programme to give you the high-performance management skills of an MBA, designed specifically for pharmaceutical/biotechnology professionals and also applicable to medical device/animal health industries

11-13 Nov 2020

& 12-14 May 2021 , 19-21 May 2021 , 10-12 Nov 2021 , 15-17 Nov 2021

Book now


Course overview

Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions.

The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with the pharmaceutical case studies from business schools.

Pharmaceutical industry context – business school pharmaceutical case studies on each module

This intensive three-day course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biopharma/generic MBA case studies, and also on your own challenges and examples. The business school case studies will help give the ‘feel’ of a full MBA and help you understand more about the strategies used in today’s pharmaceutical and associated industries.

The Pharma Mini MBA is also an invaluable guide to all that is best and most practical on an MBA course – with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster, providing a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees to focus on successful leadership and business management skills, which this programme is designed to give you.

The skills you will improve include:

  • Problem-solving
  • Seeing the bigger picture
  • Decision-making,priorities
  • Strategic leadership
  • Implementing strategy
  • Environmental awareness
  • Cross-cultural communication
  • Portfolio management
  • Strategic thinking
  • Leadership
  • Commercial awareness
  • Change management
  • Team-working
  • Project management
  • Increased confidence prioritisation

Key benefits of attending

MBA learning style of the programme

The Pharma Mini MBA learning style is ‘hands-on’ rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn from business school cases. The course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops to enhance the value of the course and, to minimise your time away from the office, there is also optional pre- and post-course work set by the programme director.

  • Develop your understanding of the key techniques of an MBA to apply to your work
  • Gain a greater understanding of the pharma industry, its drivers, challenges and opportunities
  • Hear about the latest strategic technology innovations being used and developed in the pharma industry
  • Understand what strategic thinking is and how to use strategy tools
  • Develop your leadership and strategic skills
  • Become more effective in coping with and managing change in the pharma industry
  • Explore the benefits and costs of doing an MBA
  • Take away a Mini MBA toolkit to apply to your job
  • Discuss and learn from real pharma industry case studies

 Pre-course work (sent out to delegates prior to the course)

  • Diagnostic questionnaire – your strategic competencies
  • Discussions of diagnostic output/other areas of value

Who should attend?

A ‘must-attend’ for professionals in the pharmaceutical/biopharma/medical device/animal health industries wishing to develop their business management skills for more senior levels and beyond mere technical ability. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.


Strategy and strategic challenges in the pharma industry

  • Strategy and strategic thinking and their importance in the pharma industry
  • Strategic analysis, planning and implementation
    • Environmental analysis
    • Understanding the competitive environment 
    • Strategic options
  • Applying the MBA toolkit
  • Stakeholders and their expectations in the pharma industry
  • Obtaining the value out of strategy in the pharma industry

Commercial management and leadership in the pharma industry

  • New product development and the target product profile
  • Portfolio management used in the pharma industry
  • Understanding business performance
  • The business plan
  • Diagnosing specific performance problems
  • Developing strategic alliances and collaborations in the pharma industry
  • Benefits, costs of doing an MBA and the different routes
  • The role of leadership
    • What are the core competencies of effective leaders in pharma? 
    • Leadership vs management
    • Leadership style and approaches in the pharma industry

Managing innovation in the pharma industry

  • Innovation approaches currently being adopted along the pharma value chain
  • Future innovations in pharma and the life science industries

Leading and implementing pharma strategy and change

  • Leading successful change
    • Diagnosis around change
    • How to create the conditions for successful change
    • Why people resist change and how to manage this
    • Change management including leading a structural reorganisation
    • Creating a team, department and organisation relevant to today’s pharma business needs
    • Team formation and development
  • Implementing strategy and change, essentials of planning and managing projects
    • Project management tools and techniques to use in implementing pharma projects
    • Applying key project management techniques to pharma projects
    • Understanding of cultural awareness to work more effectively with pharma colleagues

Hot topics in market access strategy

Practical application/review

  • Personal development action plan to apply the learning within your own organisation
  • Revisiting your competency assessment – what has shifted?
  • Recommended further reading
  • Practical application of tools (toolkit)


Laura Brown (More...) (11-13 Nov 2020, 12-14 May 2021, 19-21 May 2021, 10-12 Nov 2021, 15-17 Nov 2021)

Dr Laura Brown MBA, BSc (Biochemistry), BSc (Psychology), PhD, Diploma in Clinical Science, FICR, is Chair of an international pharmaceutical management consultancy and course director and lecturer for the MSc in Clinical Research at the School of Pharmacy, University of Cardiff. She has also worked as an associate with Cranfield School of Management on the leadership module of the MBA programme and their strategic thinking courses.

Dr Brown worked for Cambridge Corporate Development, an international strategy consultancy, for seven years and has extensive experience in senior management roles in the pharmaceutical industry. She has worked for Wellcome, Hoechst Marion Roussel and Phoenix International and consulted internationally with numerous pharmaceutical companies in the EU, US, Singapore, China and India. She is co-author of several management books including Be Your Own Strategy Consultant, The Ultimate Book of Business Skills and Project Management for the Pharmaceutical Industry.

Leela Barham (More...) (11-13 Nov 2020)

BSc (Economics), MSc (Health Economics) Leela Barham is an independent health economist and policy expert working on a freelance basis. This follows 7 years at a specialist economic consulting firm working in a small dedicated health and pharmaceutical team. She has more than 10 years experience in the pharmaceutical industry – both at home and abroad – and has worked for all stakeholders in the health care system ranging from patient organisations, the National Health Service, health insurers, and the pharmaceutical industry.

She has particular expertise in public and patient involvement, Patient Access Schemes/risk sharing schemes, the Cancer Drugs Fund, policy on Health Technology Assessment (HTA), and the Pharmaceutical Price Regulation Scheme (PPRS). She regularly writes on hot topics affecting the industry for Pharmaceutical Executive, Pharmaphorum and EyeforPharma and has also written for PharmaTimes, and Pharma Pricing and Reimbursement. She has also had her research published in peer review journals including The Patient and Pharmacoeconomics.

Nick Meadows (More...) (11-13 Nov 2020)

Nick Meadows has over 12 years of experience working in the life sciences industry as a management consultant, technology transfer analyst and medical research scientist. In 2016 he joined Strategy& (part of the PwC network) where he is supporting clients within the pharmaceutical industry address strategic and operational challenges in development and commercial functions.

As a consultant he has managed engagements across research and development and commercial functions of the life sciences and pharmaceutical industry. In the past 5 years his work has spanned major transformational projects in clinical operations, research and development, to and commercial strategy through direct engagement with program teams and commercial leads. In his former role at Kinapse (2011 – 2016) he led the market access service line where he supported clients optimise pricing and reimbursement outcomes for launching and development products.

In addition he has collaborated with regulators, policy makers and healthcare practitioners to provide recommendations to accelerate the development of personalised medicines. He has also developed a deep understanding of the biosimilars landscape.He holds an MBA from Saïd Business School, University of Oxford, and a PhD and BSc (Hons) in Molecular Biology from University of Queensland, Brisbane, Australia.

Book now

Book now

11-13 Nov 2020
Live webinar
11-13 Nov 2020
Live webinar
GBP 1,199.00
EUR 1,739.00
USD 1,978.00
Until 30 Sep*
Enrol now

to attend
Live webinar
12-14 May 2021
Live webinar
12-14 May 2021
Live webinar
GBP 1,199.00
EUR 1,739.00
USD 1,978.00
Until 31 Mar 21*
Enrol now
to attend
Live webinar
19-21 May 2021
Face-to-face, (venue not yet confirmed)
19-21 May 2021
(venue not yet confirmed)
GBP 1,499.00
EUR 2,099.00
USD 2,338.00
Until 7 Apr 21*
Enrol now
to attend
(venue not yet confirmed)
  • 3 days of classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy
10-12 Nov 2021
Live webinar
10-12 Nov 2021
Live webinar
GBP 1,199.00
EUR 1,739.00
USD 1,978.00
Until 29 Sep 21*
Enrol now
to attend
Live webinar
15-17 Nov 2021
Face-to-face, (venue not yet confirmed)
15-17 Nov 2021
(venue not yet confirmed)
GBP 1,499.00
EUR 2,099.00
USD 2,338.00
Until 4 Oct 21*
Enrol now
to attend
(venue not yet confirmed)
  • 3 days of classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • Abbott Biologicals BV
  • Alk Abello A/S
  • Baxter Innovations GmbH
  • Core Informatics
  • Cyberonics Europe BVBA
  • Eli Lilly Regional Operations GmbH
  • Europharma doo
  • Glaxo Smithkline Biologicals
  • GlaxoSmithKline
  • GW {harmaceuticals
  • Helsinn Healthcare S.A.
  • Hospira UK Limited
  • IBSA Institut Biochimique SA
  • Laboratoires Fournier SA
  • Life Molecular Imaging GmbH
  • Merck KGaA
  • Merck Serono SA
  • MSD Animal Health
  • Radiometer Sp. z o.o.
  • Rhein-Minapharm Biogenetics
  • Sandoz International GmbH
  • Sanquin Plasma Products B.V.
  • Strathclyde Institute of Pharmacy and Biomedical Sciences
  • Takeda Pharmaceuticals International GmbH
  • ViroVet BVBA

Overall it was a very interesting course with much knowledge and very useful techniques for strategic thinking. I really enjoyed the case studies and working in teams to accomplish the exercises. Very well done and very well organised.

Theofanis Mantourlias, Senior Manager Formulation Development, Fresenius Kabi Austria GmbH, Nov 19

Thank you for a great learning experience!

Jasper Deuring, Medical Affairs , Pfizer, May 19

Course very useful to get an overview of what a MBA could be. Laura makes the course very interactive and really interesting with many real life examples. Her knowledge of the global pharma industry is quite impressive.

Camille Rivail, Senior Manager Business Development, Avadel Pharmaceuticals SA, May 19

Good coverage of wide topic area, extremely useful for someone from a single function to get wider overview

Mark Andrews, Technical Director / QP, Deputy Managing Director, Torbay and South Devon NHS Foundation Trust, Nov 18

I think this was a very useful, practical and interesting course. I was able to adopt a strategic thinking that I will be able to implement in my work.

Aintzane Garcia, Medical Department, Faes Farma SA, Nov 18

The course gave a real insight into the MBA. There were so many tools I could take back with me and apply to my working life not only for myself , but for my colleagues. The course was a great mix of theory, case studies, external talks and media. Laura was extremely knowledgeable with great credibility within the industry. The course has made me consider a full MBA and also exploring what other courses have Laura as the trainer.

Emma Lennon, Group Manager, GW Pharmaceuticals, Nov 18

Laura Brown is a very interesting speaker

Mehdi Sellami, Scientific Director, Laboratoires Galpharma, Nov 18

For a 3 day course, we covered a good spread of techniques and information. Having the talks sparked thoughts and also provided a change of pace. The speakers were excellent and Laura's energy & experience was very much appreciated.

Lorraine Borland, Director, Strategic Projects, Sartorius-Stedim BioOutsource, Nov 18

Laura [was] very engaging, varied content, good level, Not one boring moment! Deming [offered a] good practical experience in pharma. Great to have had a chance to practically use the tools Laura recommended.

Emma Dupree, Associate Director, Compliance, AbbVie, May 18

Great energy. Best training I had in a long time.

Florent Noel, Sr Manager QA, Covis Pharma, May 18

Very interesting

Emine Akin, Marketing & Sales Junior Assistant, Chiesi Group, Nov 17

Laura is a very dynamic person that knows very well how to deliver a message. The topics are very interesting from the pharma/management point of view and articulated
- Would be interesting to have topic about pharma at geographical level

Janneth Ospina Paladines, Senior Regulatory Affairs Associate, Gilead Sciences International , Nov 17

Really good overview and opportunity to ask many questions. Great course.

Luisa Teixeira, Account Manager, Owen Mumford Ltd, Nov 17

Overall good, too little time!

Janni Hermansen, Senior PV Advisor, LEO Pharma, Nov 17

The course is very good. Gives you in three days an overall view on core subjects that management people need to know to improve. Case studies were excellent and realistic. Speakers were great

Diana Binkert, Acino International AG, May 17